Hepatitis

The Hepatitis Study Center

Dr. Mark D. Noar & Associates/Endoscopic Microsurgery Associates
specializes in the treatment of hepatitis, and is a
study center for a variety of clinical trials.
 
    Current ongoing trials include a Schering Pharmaceutical sponsored study protocol #R97-023 using Intron A and Ribavirin)for the treatment of Hepatitis CWe are actively recruiting Hepatitis C patients  for this protocol who HAVE NOT received Interferon previously

These trials involve Intron A,  3 million units injected subcutaneously three times a week along with oral Ribavirin capsules 1000 mg. daily in 2 divided doses.

Patients are monitored at regular intervals; office visits at week 0, 1, 2, 4, 8, 12, 16.......continuing at 4 week intervals through week 48
General health status, side effects, liver functions and other lab parameters are monitored at each visit by our dedicated Study Protocols Coordinator
 
An exclusive article by Roger Smith, covers clinical trials done
with ribavirin and interferon alfa combination treatment.  To read the
full article, go to:   Article on Intron A and Ribavirin
A report on a new HCV treatment in the early stages of clinical trials can be found here:        New treatment for Hep C
 
 Hepatitis A                                                      Hepatitis B                                                      Hepatitis C

 
Hepatitis Links

                MediConsult--Hep C: The Virus and the Disease --a remarkably patient-oriented site

 Back to Top

 Hep Study Center, pg.2

 Liver Diseases

 Back to Main Page



 
Special MedStaff FAQ's Visit Us Home
 
Please submit any questions or comments to:  Endoscopic Microsurgery Associates